| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | VERISIM LIFE, INC | 1 SANSOME ST STE 3500 | SAN FRANCISCO | CA | 94104-4436 | SAN FRANCISCO | USA | R43DA056084 | Development of the AI-driven model for anti-SUD drug development based on neuronal plasticity | 000 | 1 | NIH | 3/4/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2022 | VERISIM LIFE | 1 SANSOME ST | SAN FRANCISCO | CA | 94104-4436 | SAN FRANCISCO | USA | R43DA056084 | Development of the AI-driven model for anti-SUD drug development based on neuronal plasticity | 000 | 1 | NIH | 3/29/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $312,310 ) |
| | 2022 | 2022 | VERISIM LIFE, INC. | 315 MONTGOMERY ST #1036 | SAN FRANCISCO | CA | 94104-1856 | SAN FRANCISCO | USA | R43DA056084 | Development of the AI-driven model for anti-SUD drug development based on neuronal plasticity | 000 | 1 | NIH | 3/17/2022 | $312,310 |
|
|
